Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing

mBio

Volumn 5, Issue 3, 2014, Pages

  Tewhey, Ryan ^a,b   Gu, Bing ^c   Kelesidis, Theodoros ^d   Charlton, Carmen ^d,e   Bobenchik, April ^d   Hindler, Janet ^d   Schork, Nicholas J ^f   Humphries, Romney M ^d  

^a HARVARD UNIVERSITY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ALBERTA HEALTH SERVICES   (Canada)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RNA 23S; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; COAGULASE; OXAZOLIDINONE DERIVATIVE;

23S RRNA GENE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CFR GENE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RIBOPROTEIN L3 GENE; RIBOPROTEIN L4 GENE; SEQUENCE ANALYSIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; VERY ELDERLY; WHOLE GENOME SEQUENCING; BLOOD; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; YOUNG ADULT;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BLOOD; COAGULASE; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOME, BACTERIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; YOUNG ADULT;

EID: 84903978031     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00894-14     Document Type: Article

References (41)

1. Shinabarger D. 1999. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin. Investig. Drugs 8: 1195-1202. http://dx. doi. org/10. 1517/13543784. 8. 8. 1195.
2. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. 2013. The emerging problem of linezolid-resistant Staphylococcus. J. Antimicrob. Chemother. 68: 4-11. http://dx. doi. org/10. 1093/jac/dks354.
3. Long KS, Vester B. 2012. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob. Agents Chemother. 56: 603-612. http://dx. doi. org/10. 1128/AAC. 05702-11.
4. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358: 207-208. http://dx. doi. org/10. 1016/S0140-6736(01)05410-1.
5. Mazzariol A, Lo Cascio G, Kocsis E, Maccacaro L, Fontana R, Cornaglia G. 2012. Outbreak of linezolid-resistant Staphylococcus haemolyticus in an Italian intensive care unit. Eur. J. Clin. Microbiol. Infect. Dis. 31: 523-527. http://dx. doi. org/10. 1007/s10096-011-1343-6.
6. Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G, Jones RN. 2010. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J. Antimicrob. Chemother. 65: 2329-2335. http://dx. doi. org/10. 1093/jac/dkq331.
7. Gales AC, Sader HS, Andrade SS, Lutz L, Machado A, Barth AL. 2006. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. Int. J. Antimicrob. Agents 27: 300-302. http://dx. doi. org/10. 1016/j. ijantimicag. 2005. 11. 008.
8. Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA. 2008. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob. Agents Chemother. 52: 1570-1572. http://dx. doi. org/10. 1128/AAC. 01098-07.
9. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, Mankin AS. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64: 1506-1514. http://dx. doi. org/10. 1111/j. 1365-2958. 2007. 05744. x.
10. Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. 2005. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol. Microbiol. 57: 1064-1073. http://dx. doi. org/10. 1111/j. 1365-2958. 2005. 04754. x.
11. Smith LK, Mankin AS. 2008. Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. Antimicrob. Agents Chemother. 52: 1703-1712. http://dx. doi. org/10. 1128/AAC. 01583-07.
12. Flamm RK, Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. 2012. LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers). Diagn. Microbiol. Infect. Dis. 74: 54-61. http://dx. doi. org/10. 1016/j. diagmicrobio. 2012. 05. 012.
13. Schwarz S, Werckenthin C, Kehrenberg C. 2000. Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri. Antimicrob. Agents Chemother. 44: 2530-2533. http://dx. doi. org/10. 1128/AAC. 44. 9. 2530-2533. 2000.
14. Mendes RE, Deshpande L, Rodriguez-Noriega E, Ross JE, Jones RN, Morfin-Otero R. 2010. First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization. J. Clin. Microbiol. 48: 3041-3043. http://dx. doi. org/10. 1128/JCM. 00880-10.
15. Locke JB, Rahawi S, Lamarre J, Mankin AS, Shaw KJ. 2012. Genetic environment and stability of cfr in methicillin-resistant Staphylococcus aureus CM05. Antimicrob. Agents Chemother. 56: 332-340. http://dx. doi. org/10. 1128/AAC. 05420-11.
16. Feng J, Lupien A, Gingras H, Wasserscheid J, Dewar K, Légaré D, Ouellette M. 2009. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res. 19: 1214-1223. http://dx. doi. org/10. 1101/gr. 089342. 108.
17. Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF. 2010. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphy-lococcus aureus. Antimicrob. Agents Chemother. 54: 5406-5412. http://dx. doi. org/10. 1128/AAC. 00580-10.
18. Calderón-Jaimes E, Espinosa de los Monteros LE, Avila-Beltrán R. 2002. Epidemiology of drug resistance: the case of Staphylococcus aureus and coagulase-negative staphylococci infections. Salud Publica Mex. 44: 108-112. http://dx. doi. org/10. 1590/S0036-36342002000200004.
19. Potoski BA, Adams J, Clarke L, Shutt K, Linden PK, Baxter C, Pasculle AW, Capitano B, Peleg AY, Szabo D, Paterson DL. 2006. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin. Infect. Dis. 43: 165-171. http://dx. doi. org/10. 1086/505114.
20. Tegnell A, Grabowska K, Jacobsson A, Andersson M, Giesecke J, Ohman L. 2003. Study of developed resistance due to antibiotic treatment of coagulase-negative staphylococci. Microb. Drug Resist. 9: 1-6. http://dx. doi. org/10. 1089/107662903322541838.
21. Farrell DJ, Mendes RE, Ross JE, Jones RN. 2009. Linezolid surveillance program results for 2008 (LEADER Program for 2008). Diagn. Microbiol. Infect. Dis. 65: 392-403. http://dx. doi. org/10. 1016/j. diagmicrobio. 2009. 10. 011.
22. Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. 2011. LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6, 414 clinical isolates from 56 medical centers in the United States. Antimicrob. Agents Chemother. 55: 3684-3690. http://dx. doi. org/10. 1128/AAC. 01729-10.
23. Jones RN, Ross JE, Castanheira M, Mendes RE. 2008. United States resistance surveillance results for linezolid (LEADER Program for 2007). Diagn. Microbiol. Infect. Dis. 62: 416-426. http://dx. doi. org/10. 1016/j. diagmicrobio. 2008. 10. 010.
24. Pillar CM, Draghi DC, Sheehan DJ, Sahm DF. 2008. Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs. Diagn. Microbiol. Infect. Dis. 60: 221-224. http://dx. doi. org/10. 1016/j. diagmicrobio. 2007. 08. 007.
25. Schoenfelder SM, Lange C, Eckart M, Hennig S, Kozytska S, Ziebuhr W. 2010. Success through diversity-how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int. J. Med. Microbiol. 300: 380-386. http://dx. doi. org/10. 1016/j. ijmm. 2010. 04. 011.
26. Liakopoulos A, Spiliopoulou I, Damani A, Kanellopoulou M, Schoina S, Papafragas E, Marangos M, Fligou F, Zakynthinos E, Makris D, Protonotariou E, Tsiapara F, Filos K, Diza E, Anastassiou ED, Petinaki E. 2010. Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J. Antimicrob. Chemother. 65: 1070-1071. http://dx. doi. org/10. 1093/jac/dkq065.
27. Wong A, Reddy SP, Smyth DS, Aguero-Rosenfeld ME, Sakoulas G, Robinson DA. 2010. Polyphyletic emergence of linezolid-resistant staphylococci in the United States. Antimicrob. Agents Chemother. 54: 742-748. http://dx. doi. org/10. 1128/AAC. 00621-09.
28. Billal DS, Feng J, Leprohon P, Légaré D, Ouellette M. 2011. Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. BMC Genomics 12: 512. http://dx. doi. org/10. 1186/1471-2164-12-512.
29. Flamm RK, Mendes RE, Ross JE, Sader HS, Jones RN. 2013. Linezolid surveillance results for the United States: LEADER surveillance program 2011. Antimicrob. Agents Chemother. 57: 1077-1081. http://dx. doi. org/10. 1128/AAC. 02112-12.
30. Shen J, Wang Y, Schwarz S. 2013. Presence and dissemination of the multiresistance gene cfr in Gram-positive and gram-negative bacteria. J. Antimicrob. Chemother. 68: 1697-1706. http://dx. doi. org/10. 1093/jac/dkt092.
31. Mendes RE, Deshpande LM, Costello AJ, Farrell DJ. 2012. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U. S. hospitals. Antimicrob. Agents Chemother. 56: 4656-4661. http://dx. doi. org/10. 1128/AAC. 00279-12.
32. Locke JB, Hilgers M, Shaw KJ. 2009. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob. Agents Chemother. 53: 5275-5278. http://dx. doi. org/10. 1128/AAC. 01032-09.
33. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for Bacteria that grow aerobically; approved standard, 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
34. Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, Sakoulas G. 2012. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 56: 6051-6053. http://dx. doi. org/10. 1128/AAC. 01318-12.
35. Fisher S, Barry A, Abreu J, Minie B, Nolan J, Delorey TM, Young G, Fennell TJ, Allen A, Ambrogio L, Berlin AM, Blumenstiel B, Cibulskis K, Friedrich D, Johnson R, Juhn F, Reilly B, Shammas R, Stalker J, Sykes SM, Thompson J, Walsh J, Zimmer A, Zwirko Z, Gabriel S, Nicol R, Nusbaum C. 2011. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol. 12: R1. http://dx. doi. org/10. 1186/gb-2011-12-S1-P1.
36. Hernandez D, François P, Farinelli L, Osterås M, Schrenzel J. 2008. De novo bacterial genome sequencing: millions of very short reads assembled on a desktop computer. Genome Res. 18: 802-809. http://dx. doi. org/10. 1101/gr. 072033. 107.
37. Lunter G, Goodson M. 2011. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 21: 936-939. http://dx. doi. org/10. 1101/gr. 111120. 110.
38. Liakopoulos A, Neocleous C, Klapsa D, Kanellopoulou M, Spiliopoulou I, Mathiopoulos KD, Papafrangas E, Petinaki E. 2009. A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis. J. Antimicrob. Chemother. 64: 206-207. http://dx. doi. org/10. 1093/jac/dkp167.
39. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760. http://dx. doi. org/10. 1093/bioinformatics/btp324.
40. Bradley RK, Roberts A, Smoot M, Juvekar S, Do J, Dewey C, Holmes I, Pachter L. 2009. Fast statistical alignment. PLoS Comput. Biol. 5: e1000392. http://dx. doi. org/10. 1371/journal. pcbi. 1000392.
41. Stamatakis A, Ludwig T, Meier H. 2005. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456-463. http://dx. doi. org/10. 1093/bioinformatics/bti191.